Indian pharmaceutical companies lag behind global peers in ESG practices, facing regulatory, awareness, and resource ...

India's apex drug advisory body has been inactive since its term ended in October. This was brought to the health ministry's ...

India on Wednesday reaffirmed its commitment to global pharmaceutical standardisation and regulatory convergence.

Shares of Abbott India surged 5.60% higher at ₹27,605.45 on the BSE on Tuesday. The pharma stock reacted positively to the ...

India's J B Chemicals & Pharmaceuticals reported a bigger third-quarter profit on Tuesday, helped by sustained domestic demand for its drugs for chronic and acute conditions.

By Kashish Tandon and Rishika Sadam HYDERABAD/BENGALURU (Reuters) -Sun Pharmaceutical, India's largest drugmaker by revenue, ...

India's trade surplus with the US and its reliance on American trade policy for US dollar earnings make it a key player.

Indian drugmaker Alembic Pharmaceuticals reported a lower third-quarter profit on Monday, weighed down by weak local sales of its drugs that treat acute illnesses.

Today, companies including Religare Enterprises, Gland Pharma, Fortis Malar Hospitals, Aditya Birla Capital, Alembic Pharma, ...